http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS
Vincent, M.D.; Kuruvilla, M.S.; Leighl, N.B.; Kamel-Reid, S. MULTIMED INC 2012 p.S33-S44
Drug resistance and its significance for treatment decisions in non-small-cell lung cancer
Tsvetkova, E.; Goss, G.D. MULTIMED INC 2012 p.S45-S51
Future of personalized medicine in non-small-cell lung cancer
Hirsh, V. MULTIMED INC 2012 p.S86-S86
Ofiara, L.M.; Navasakulpong, A.; Ezer, N.; Gonzalez, A.V. MULTIMED INC 2012 p.S16-S23
The importance of multidisciplinary team management of patients with non-small-cell lung cancer
Ellis, P.M. MULTIMED INC 2012 p.S7-S15
Personalized choice of maintenance therapies in non-small-cell lung cancer
Blais, N.; Corrales-Rodriguez, L. MULTIMED INC 2012 p.S64-S72
Black, A.; Morris, D. MULTIMED INC 2012 p.S73-S85
The role of molecular pathology in non-small-cell lung carcinoma-now and in the future
Brandao, G.D.A.; Brega, E.F.; Spatz, A. MULTIMED INC 2012 p.S24-S32
Supportive care treatments for toxicities of anti-EGFR and other targeted agents
Melosky, B. MULTIMED INC 2012 p.S59-S63